Biomimetic Pharmaceuticals, Inc.
Country not established
- Devices
- 1
What Biomimetic Pharmaceuticals, Inc. makes
Biomimetic Pharmaceuticals, Inc. produces an osteomimetic synthetic bone matrix designed to support bone regeneration and healing in surgical applications.
The company’s portfolio is regulated under FDA Class II devices and requires 510(k) clearance. The products are listed in the FDA’s 510(k) registry and are based in the United States.
Catalogue
Osteomimetic Synthetic Bone Matrix Ref K051775
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Biomimetic Pharmaceuticals, Inc. have in the registry?
The registry currently lists 1 device for Biomimetic Pharmaceuticals, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Biomimetic Pharmaceuticals, Inc.'s devices?
Among its 1 most recently registered device, Biomimetic Pharmaceuticals, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Biomimetic Pharmaceuticals, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Biomimetic Pharmaceuticals, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Biomimetic Pharmaceuticals, Inc. in the registry?
The most recently registered devices listed for Biomimetic Pharmaceuticals, Inc. include OSTEOMIMETIC SYNTHETIC BONE MATRIX.